DocDollars

Pharmacosmos Therapeutics Inc.

NJ · United States · Reporting entity ID 100000801827

Total reported 2019–2025
$5.12M
#698 of 2,960 reporting companies — 0% of all reported industry payments
$4.83M in general payments across 24,360 records, plus $293K in research funding across 98 records.

How it breaks down

General payments $4,826,085
Research funding $292,674

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Pharmacosmos Therapeutics Inc. reported $5.12M to US doctors and teaching hospitals from 2019 to 2025, ranking #698 of 2,960 reporting companies. 6% of that was research funding and 94% general payments such as consulting, speaking, food and travel. 24,360 general payment records and 98 research records were filed.

Common questions about Pharmacosmos Therapeutics Inc.

How much has Pharmacosmos Therapeutics Inc. paid US doctors?

Pharmacosmos Therapeutics Inc. reported $5,118,759 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $4,826,085 in general payments, $292,674 in research funding.

How does Pharmacosmos Therapeutics Inc. rank among drug and device companies?

It ranks #698 of 2,960 reporting entities by total reported value, about 0% of all industry payments in the dataset.

Does a payment from Pharmacosmos Therapeutics Inc. mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.